Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H14FO3P |
Molecular Weight | 184.1457 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OP(F)(=O)OC(C)C
InChI
InChIKey=MUCZHBLJLSDCSD-UHFFFAOYSA-N
InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3
DescriptionSources: https://www.drugs.com/mmx/isoflurophate.html
Sources: https://www.drugs.com/mmx/isoflurophate.html
Isofluorophate (diisopropyl fluorophosphate) is an irreversile acetylcholinesterase inhibitor. It was used in ophthalmology as a miotic agent in treatment of chronic glaucoma.
Originator
Sources: http://www.fluoride-history.de/p-mfp.htm
Curator's Comment: On Dec. 11th, 1941, Bernard Charles Saunders, University of Cambridge, UK, reported at a Ministry of Supply meeting in London the highly toxic nature of an ester of monofluorophosphoric acid, diisopropyl fluorophosphate (DFP), as a lethal inhalant.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20189400 |
6.0 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | FLOROPRYL Approved UseIsoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme. Launch Date1957 |
PubMed
Title | Date | PubMed |
---|---|---|
Granzymes: a family of lymphocyte granule serine proteases. | 2001 |
|
Bioconversion of vitamin E acetate in human skin. | 2001 |
|
Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: protection by antioxidants. | 2001 Apr |
|
Correlation of binding sites for diisopropyl phosphorofluoridate with cholinesterase and neuropathy target esterase in membrane and cytosol preparations from hen. | 2001 Apr |
|
Nitric oxide modulates high-energy phosphates in brain regions of rats intoxicated with diisopropylphosphorofluoridate or carbofuran: prevention by N-tert-butyl-alpha-phenylnitrone or vitamin E. | 2001 Aug |
|
Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds. | 2001 Dec |
|
Identification, purification, and characterization of a thermally stable lipase from rice bran. A new member of the (phospho) lipase family. | 2001 Dec |
|
Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo. | 2001 Dec |
|
Altered time course of mRNA expression of alpha tubulin in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP). | 2001 Jan |
|
New subtilisin-like collagenase from leaves of common plantain. | 2001 Jun |
|
Crystal structure of diisopropylfluorophosphatase from Loligo vulgaris. | 2001 Jun |
|
Alteration in cytoskeletal protein levels in sciatic nerve on post-treatment of diisopropyl phosphorofluoridate (DFP)-treated hen with phenylmethylsulfonyl fluoride. | 2001 Mar |
|
Studies on trypsin-modified bovine and human lens acylpeptide hydrolase. | 2001 Mar |
|
Bioelectrochemical analysis of neuropathy target esterase activity in blood. | 2001 Mar 1 |
|
Identification of the intracellular polyhydroxyalkanoate depolymerase gene of Paracoccus denitrificans and some properties of the gene product. | 2001 Mar 15 |
|
Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. | 2001 May |
|
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism. | 2001 Nov 23 |
|
Diisopropylfluorophosphate alters retinal neurotransmitter levels and reduces experimentally-induced myopia. | 2001 Oct |
|
The catalytic domain of human neuropathy target esterase mediates an organophosphate-sensitive ionic conductance across liposome membranes. | 2001 Oct |
|
Properties of the hatching enzyme from Xenopus laevis. | 2001 Sep |
|
Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages. | 2001 Sep 21 |
|
Purification, cloning and characterization of a GPI inositol deacylase from Trypanosoma brucei. | 2001 Sep 3 |
|
Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. | 2001 Sep 4 |
|
Differential alteration of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in the central nervous system of hens treated with diisopropylphosphorofluoridate (DFP). | 2002 Apr |
|
Analysis of organophosphorus compound adducts of serine proteases by liquid chromatography-tandem mass spectrometry. | 2002 Aug 25 |
|
Rapid assessment of organophosphorous/carbamate exposure in the bivalve mollusc Mytilus edulis using combined esterase activities as biomarkers. | 2002 Dec 3 |
|
Characterization of the residues involved in the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. | 2002 Feb 26 |
|
Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant. | 2002 Jan |
|
Different expressions of organophosphate-resistant acetylcholinesterases in the bivalve mollusk Scapharca inaequivalvis living in three different habitats. | 2002 Jan |
|
Lecithin: cholesterol acyltransferase is insufficient to prevent oxidative modification of low-density lipoprotein. | 2002 Jan |
|
Purification and characterization of hemolymph juvenile hormone esterase from the cricket, Gryllus assimilis. | 2002 Jan |
|
Juvenile hormone catabolism and oviposition in the codling moth, Cydia pomonella, as functions of age, mating status, and hormone treatment. | 2002 Jan |
|
Protein levels of neurofilament subunits in the hen central nervous system following prevention and potentiation of diisopropyl phosphorofluoridate (DFP)-induced delayed neurotoxicity(1). | 2002 Jan 1 |
|
Chrysobactin-dependent iron acquisition in Erwinia chrysanthemi. Functional study of a homolog of the Escherichia coli ferric enterobactin esterase. | 2002 Jan 25 |
|
Reelin is a serine protease of the extracellular matrix. | 2002 Jan 4 |
|
Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis. | 2002 Jul |
|
Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase. | 2002 Jul |
|
Purification and characterization of an esterase from Acinetobacter lwoffii I6C-1. | 2002 Jun |
|
Pyridostigmine bromide modulates the dermal disposition of [14C]permethrin. | 2002 Jun 15 |
|
Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs. | 2002 Jun 15 |
|
Nanocrystalline metal oxides as destructive adsorbents for organophosphorus compounds at ambient temperatures. | 2002 Jun 3 |
|
Dipeptidyl peptidase with strict substrate specificity of an anaerobic periodontopathogen Porphyromonas gingivalis. | 2002 Mar 19 |
|
Degradation of glyceraldehyde-3-phosphate dehydrogenase induced by acetylleucine chloromethyl ketone in U937 cells. | 2002 May 15 |
|
Characterization of the receptor-destroying enzyme activity from infectious salmon anaemia virus. | 2002 Nov |
|
A mechanism-based probe for gp120-Hydrolyzing antibodies. | 2002 Nov 4 |
|
Purification and characterization of PrbA, a new esterase from Enterobacter cloacae hydrolyzing the esters of 4-hydroxybenzoic acid (parabens). | 2003 Apr 11 |
|
AMPA receptor potentiation by acetylcholinesterase is age-dependently upregulated at synaptogenesis sites of the rat brain. | 2003 Feb |
|
Structural and enzymatic characterization of physarolisin (formerly physaropepsin) proves that it is a unique serine-carboxyl proteinase. | 2003 Feb 21 |
|
Lesions of rat skeletal muscle after local block of acetylcholinesterase and neuromuscular stimulation. | 2003 Jun |
|
The cholinesterase inhibitor DFP facilitates the expression of paradoxical sleep (PS) propensity in rats subjected to short-term PS deprivation. | 2003 Mar 7 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/mmx/isoflurophate.html
Topical, to the conjunctiva, a thin strip (approximately 0.5 cm) of a 0.025% ointment once every three days to three times a day.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20189400
Recombinant AChE was quantitated using the extinction coefficient 119, 650 M-1 cm-1 calculated from its amino acid sequence. AChE (34 nM) was assayed using Ellman’s reagent using 160 uM acetylthiocholine and 300 uM 5,50-dithiobis-2-ntirobenzoic acid (DTNB). Thiocholine released by the enzyme reacts with excess DTNB, resulting in the formation of the thionitrobenzoate anion, which absorbs at 412 nm. To assess IC50, the inhibitors were solubilized in isopropanol and used in volumes of less than 5% of the total reaction volume. AChE (34 nM) was incubated for 30 min with each compound at an array of concentrations. The residual activity of the enzyme was assayed using 500 uM acetylthiocholine, a saturating concentration 10-fold higher than the Km of 46 uM for this substrate.
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47792
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
||
|
EPA PESTICIDE CODE |
356100
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
||
|
WHO-ATC |
S01EB07
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID1040667
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
55-91-4
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL1025
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
DIISOPROPYL FLUOROPHOSPHATE
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
1494
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
12UHW9R67N
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
6027
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | RxNorm | ||
|
17941
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
DB00677
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
200-247-6
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
m6492
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
D007531
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
100000077389
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
SUB14274MIG
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
2133
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
5936
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
727370
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
C65979
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY |
ACTIVE MOIETY